Possible hepatotoxicity of chronic marijuana usage
Keywords:
Marijuana, Cannabinoids, Illicit drugs, Liver, Addictive behaviorAbstract
CONTEXT: Hepatotoxicity is a potential complication from the usage of various illicit drugs, possibly consequent to their liver metabolism, but information on this is scarce in the medical literature. OBJECTIVE: To study the occurrence of clinical and laboratory hepatic alterations in chronic marijuana users, from the use of marijuana on its own or in association with other legal or illicit drugs. TYPE OF STUDY: transversal study SETTING: Hospital Espírita de Marília, Marília, São Paulo, Brazil PARTICIPANTS: The study was made among 123 patients interned in the Hospital Espírita de Marília from October 1996 to December 1998, divided into 3 groups: 26 (21%) using only marijuana, 83 (67.5%) using marijuana and crack, and 14 (11.4%) consuming marijuana and alcohol. PROCEDURES AND MAIN MEASUREMENTS: Patients were examined clinically with special emphasis on types of drugs used, drug intake route, age when consumption began, length and pattern of usage, presence of tattooing, jaundice, hepatomegaly and splenomegaly. Serum determinations of total proteins, albumin, globulin, total and fractions of bilirubin, aspartate (AST) and alanine (ALT) aminotransferases, alkaline phosphatase (AP), gamma-glutamyltransferase and prothrombin activity were performed. RESULTS: Among users of only marijuana, hepatomegaly was observed in 57.7% and splenomegaly in 73.1%, and slightly elevated AST (42.3%), ALT (34.6%) and AP (53.8%). The three groups did not differ significantly in the prevalence of hepatomegaly, splenomegaly and hepatosplenomegaly. The group using both marijuana and alcohol showed the highest prevalence of alterations and highest levels of aminotransferases. Mean AP levels were above normal in all groups. CONCLUSIONS: Chronic marijuana usage, on its own or in association with other drugs, was associated with hepatic morphologic and enzymatic alterations. This indicates that cannabinoids are possible hepatotoxic substances.
Downloads
References
Galduróz JCF, Carlini EA. O uso de drogas psicotrópicas entre estudantes do 1o e 2o graus em dez capitais brasileiras: comparação de três levantamentos - 1987/1989/ 1993. Temas. 1996;26(52):264-74.
Hall W, Johnston L, Donnelly N. The epidemiology of canna- bis: use and its consequences. In: Kalant H, Corrigal W, Hall W, Smart R, editors. The health effects of cannabis. Toronto: Addiction Research Foundation; 1998. p. 44-61.
Milman DH. The role of maribuana in patterns of drug abuse by adolescents. J Pediatr. 1969;74(2):283-90.
Adams IB, Martin BR. Cannabis: pharmacology and toxicology in animals and humans. Addiction. 1996;91(11):1585-614.
Hauschild TB. Marijuana. Mil Med. 1971;136(2):105-9.
Howlett AC, Fleming RM. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol Pharmacol. 1984;26(3):532-8.
Caulfield MP, Brown DA. Cannabinoid receptor agonists in- hibit Ca current in NG108-15 neuroblastoma cells via a per- tussis toxin-sensitive mechanism. Br J Pharmacol. 1992;106(2):231-2.
Deadwyler SA, Hampson RE, Bennett BA, et al. Cannabinoids modulate potassium current in cultured hippocampal neurons. Receptors Channels. 1993;1(2):121-34.
Chaudhry A, Thompson RH, Rubin RP, Laychock SG. Rela- tionship between delta-9-tetrahydrocannabinol-induced ara- chidonic acid release and secretagogue-evoked phosphoinositide breakdown and Ca2+ mobilization of exocrine pancreas. Mol Pharmacol. 1988;34(4):543-8.
Nahas G, Sutin K, Bennett WM. Review of Marihuana and Medicine. N Engl J Med. 2000;343(7):514-5.
Bloom JW, Kaltenborn WT, Paoletti P, Camilli A, Lebowitz MD. Respiratory effects of non-tobacco cigarettes. Br Med J (Clin Res Ed). 1987;295(6612):1516-8.
Tashkin DP, Fligiel S, Wu TC, et al. Effects of habitual use of marijuana and/or cocaine on the lung. In: Chiang CN, Hawks RL, editors. Research findings on smoking of abused substances. National Institute on Drug Abuse Research Monograph 99. Rockville, Maryland: National Institute on Drug Abuse; 1990. p. 63-87. Available from URL: http://www.drugabuse.gov/pdf/ monographs/99.pdf. Accessed in 2004 (May 10).
Hall LW, Solowij N, Lemon J. The health and psychological consequences of cannabis use. National Drug Strategy Mono- graph Series no. 25. Canberra: Australian Government Pub- lishing Service; 1994.
Hollister LE. Marijuana and immunity. J Psychoactive Drugs. 1992;24(2):159-64.
Nahas GG, Osserman EF. Altered serum immunoglobulin con- centration in chronic marijuana smokers. In: Friedman H, Spector S, Klein TW, editors. Drugs of abuse, immunity, and immunodeficiency. New York: Plenum Press; 1991. p. 25-32.
Hall W, Solowij N. Adverse effects of cannabis. Lancet. 1998;352(9140):1611-6.
Porto JAF. Aparelho Digestivo. In: Romeiro JV, Tarantino AB, editors. Semiologia Médica. 12a ed.. Rio de Janeiro: Guanabara Koogan; 1983. p. 343-446.
Surós Batllo A. Aparelho digestivo. In: Surós Forns J , Surós Batllo J, Surós Batllo A, editores. Semiologia médica e técnica exploratória, 6a ed. Rio de Janeiro: Guanabara Koogan ; 1981. p. 313-482.
Kew MC, Bersohn I, Siew S. Possible hepatotoxicity of canna- bis. Lancet. 1969;1(7594):578-9.
Indian Hemp Drugs Commission. Marijuana: report of The Indian Hemp Drugs Commission, 1893-1894. Maryland: Sil- ver Spring; 1969.
Hochman JS, Brill NQ. Chronic marihuana usage and liver function. Lancet. 1971;2(7728):818-9.
Cooper AD, Niejadlik D, Huston K. Liver disease in nonparenteral drug abusers. JAMA. 1975;233(9):964-96.
Galduróz JCF, Noto AR, Carlini EA. O abuso de inalantes en- tre estudantes de 1o e 2o graus da rede pública de ensino: as drogas de início? Temas. 1996;26(51):126-36.
Leite MC. Relações entre dependência de cocaína e transtornos depressivos: contribuição para o estudo da co-morbidade psiquiátrica em pacientes dependentes de substâncias psicoativas.. [dissertation]. São Paulo (SP): Faculdade de Medicina da Universidade de São Paulo; 1995.
Odo SA, Araújo AC, Santos AF, et al. Consumo de maconha entre dependentes de cocaína em tratamento ambulatorial: níveis de consumo, confiabilidade do relato e implicações para o tratamento. [Marijuana use among cocaine dependents in out- patient treatment: level of use, reliability of the report and impli- cations for the treatment]. Rev Psiquiatr Clin. 2000;27(1):43-9.
Bates B. Abdome. In: Bates B. Propedêutica médica, 4a ed. Rio de Janeiro: Guanabara; 1990. p. 312-37 .
Porto CC. Abdome. In: Porto CC. Exame clínico, 3a ed. Rio de Janeiro: Guanabara Koogan; 1996. p. 312-41.
Munson AE, Fehr KO. Immunological effects of cannabis. In: Fehr KO, Kalant H, editors. Adverse health and behavioral con- sequences of cannabis use. Toronto: Addiction Research Foun- dation; 1983. p. 257-354.
Munro S, Thomas KL, Abu-Shaar M. Molecular characteriza- tion of a peripheral receptor for cannabinoids. Nature. 1993;365(6441):61-5.
Bouaboula M, Rinaldi M, Carayon P, et al. Cannabinoid- receptor expression in human leukocytes. Eur J Biochem. 1993;214(1):173-80.
Konttinen A, Hartel G, Louhija A. Multiple serum enzyme analyses in chronic alcoholics. Acta Med Scand. 1970,188(4):257-64.
Teschke R, Neuefeind M, Nishimura AM, et al. Hepatic gamma- glutamyltransferase activity in alcoholic fatty liver: comparison with other enzymes in man and rats. Gut. 1983;24(7):625-30.
Carlini EA, Karniol IG, Renault PF, Schuster CR. Effects of marihuana in laboratory animals and in man. Br J Pharmacol. 1974;50(2):299-309.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM IV). 4th ed. Washington: American Psychiatric Association; 1994.
Booth RE, Watters JK, Chitwood DD. HIV risk-related sex behaviors among injection drug users, crack smokers, and in- jection drug users who smoke crack. Am J Public Health. 1993;83(8):1144-8.
Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med. 1996;334(26):1691-6.
Mincis R, Mincis M. Hepatites agudas pelos vírus A, B, C. In: Mincis M, editor. Gastroenterologia & hepatologia, diagnóstico e tratamento. São Paulo: Lemos Editorial; 1997. p.607-12.
Kage M, Ogasawara S, Kosai K, et al. Hepatitis C virus RNA present in saliva but absent in breast-milk of the hepatitis C carrier mother. J Gastroenterol Hepatol. 1997;12(7):518-21.
Cooper AD, Niejadlik D, Huston K. Liver disease in nonparenteral drug abusers. JAMA. 1975;233(9):964-6.
Schiff ER. Update in hepatology. Ann Intern Med. 2000;132(6):460-6.
Louria DB. Some aspects of the current drug scene with em- phasis on drugs in use by adolescents. Pediatrics. 1968;42(6):904-11.
Bloch E. Effects of marihuana and cannabinoids on reproduc- tion, endocrine function, development and chromosomes. In:Fehr KO, Kalant H, editors. Adverse health and behavioral con- sequences of cannabis use. Toronto: Addiction Research Foun- dation; 1983. p. 355-432.
Siegel RK. Cocaine and sexual dysfunction: the curse of mama coca. J Psychoactive Drugs. 1982;14(1-2):71-4.
Souto FJ, Fontes CJ, Martelli CM, et al. Hepatitis C virus preva- lence among an immigrant community to the southern Amazon, Brazil. Mem Inst Oswaldo Cruz. 1999;94(6):719-23.
Tengan FM, Eluf-Neto J, Cavalheiro NP, Barone AA. Sexual transmission of hepatitis C virus. Rev Inst Med Trop São Paulo. 2001;43(3):133-7.
Ferraz MLG, Silva AEB. Hepatites crônicas pelo vírus B. In: Mincis M, editor. Gastroenterologia & Hepatologia, Diagnóstico e Tratamento. São Paulo: Lemos Editorial; 1997. p.613-20.
Edlin BR, Faruque S, Word CO, McCoy CB, Willams IT. Preva- lence of hepatitis C virus infection among crack cocaine smok- ers in three U.S. cities. [abstrat]. Gastroenterology. 1999;116:A1206.
Gopal DV, Rosen HR. Abnormal findings on liver function tests. Interpreting results to narrow the diagnosis and establish a prognosis. Postgrad Med. 2000;107:100-2, 105-9, 113-4.
